Publications
The Barometer of Engagement
Building sustainable patient-centric trials to weather the storm of COVID-19 involves the utilisation of smart connected devices and packaging to reduce the burden on patients
Read MoreOur latest article in Applied Clinical Trials Online discusses the Role of Data Science and Understanding Patient Behavior.
Our latest article in Applied Clinical Trials Online discusses the Role of Data Science and Understanding Patient Behavior.
Read MoreOur latest article in PMPS discusses how non-adherence to medication has been costing lives and money for decades but SmartPackaging solutions are now solving the age-old problem.
This article is taken from Pharmaceutical Manufacturing and Packing Sourcer February 2021, pages 46-49. © Samedan Ltd
Read MoreWe see an uptake in Remote, Decentralized and Hybrid Trials. Do you?
We are soon leaving a very difficult year in all aspects. We lived with global pandemic and civil troubles in the news all year long. However, our Scientific Lead, Bernard Vrijens sees an uptake in remote, decentralized, and hybrid trials. Because humans will always learn, and innovate from difficulties. That’s exactly what PharmaVoice magazine tried…
Read MoreAARDEX Group partners with BIOCORP to extend digital solutions for precision medication adherence
AARDEX Group, the world leader in medication adherence solutions, today announced a strategic partnership with BIOCORP, a French company specialized in the design, development and manufacture of innovative medical devices.
Read MoreAARDEX announces the world’s first DIGITAL MEDICATION ADHERENCE MONITORING solution fully integrated in the clinical trial platform by a top 10 pharma company.
AARDEX is proud to announce the integration of its MEMS® Adherence Software by a major pharmaceutical company. It’s the first end-to-end integration of electronically compiled dosing histories using smart packages from interactive response technology (IRT) into electronical data capture systems (EDC) to improve medication adherence data accuracy in clinical trials. This collaboration, initiated in 2015,…
Read MoreHow digital medication adherence monitoring increases the impact of innovative adherence research?
MEMS® has been a part of successful adherence research for more than 30 years.Download this adherence compendium and find out how digital medication adherence monitoring increases the impact of academic research findings.
Read MoreAARDEX Group announces the opening of a new office in the U.S.
By establishing itself in the U.S., the Group aims to strengthen its business and maintain its position as market leader in digital adherence monitoring systems. Joe Keenan will lead the business development for the pharma and biotech industry in North America. With over 70% of AARDEX’s customers based in the U.S., this new office will support…
Read MoreUsing data science to detect key changes in medication intake behaviors.
Electronic monitoring, a digital technology based on smart packages, enables the most objective and precise adherence monitoring. By using an evidence-based digital adherence monitoring system, Sponsors and HCPs improve drug efficacy by managing patient adherence to the medications. In this Medium article (the online publishing platform), AARDEX presents the latest results from its data science…
Read MoreHow smart packages enable digital medication adherence monitoring for successful clinical trials?
50 % of patients involved in clinical trials do not take their medication as prescribed, resulting in underestimated drug efficacy and delayed approval of the investigational product. Poor medication adherence is thus a threat to drug development. Stop using unreliable methods to assess medication adherence and maximize the chances of success in your clinical trials…
Read More